Abasaglar

Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes

The deal focuses on addressing critical unmet medical needs

The acquisition is to advance treatments for serious autoimmune and allergic diseases

The agreement for up to ten biosimilar assets represents one of largest ever biosimilar collaborations for the company

The UK is the first country in Europe to authorise the oral medication

Around 60,000 people in the US get pancreatic cancer each year, with an estimated 50,000 deaths projected annually

The report forecasts a rise in cases in the US, the UK, Canada, Australia and Europe

The acquisition will advance therapies for treatment-resistant depression and other mental health conditions

This is the first treatment breakthrough in pulmonary fibrosis in over a decade

Pompe disease is a rare, progressive neuromuscular disease, with infantile onset being the most aggressive form

The collaboration began in 2013 and was later expanded in 2020 and 2023

SPMS is a debilitating stage of MS where patients experience increasing levels of disability